Synektik

Synektik Net Margin

The Net Profit Margin of Synektik (SNT.WA) as of Oct 31, 2026 is 15.00 %. In the previous year, Net Profit Margin was 13.56 % — a change of 10.61% (higher).

Net Margin

15.00 %

YoY

10.61%

Last updated:

Net Profit Margin of Synektik is 2025 15.00 % . Net Profit Margin of Synektik was 2024 13.56 % . It decreases by 10.61% higher compared to the previous year.

For Synektik, the net margin of 15.0% is up versus 6.5% a few years ago.

The Synektik Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
9.77 PLN
Jan 1, 2019
6.78 PLN
Jan 1, 2020
7.03 PLN
Jan 1, 2021
6.52 PLN
Jan 1, 2022
6.17 PLN
Jan 1, 2023
11.74 PLN
Jan 1, 2024
13.56 PLN
Jan 1, 2025
15.00 PLN
The Synektik Net Margin history
YEARNet MarginYoY
15.00 %+10.61%
13.56 %+15.53%
11.74 %+90.13%
6.17 %-5.28%
6.52 %-7.24%
7.03 %+3.66%
6.78 %-30.64%
9.77 %+50.57%
6.49 %+726.78%
0.79 %-151.88%
-1.51 %-133.04%
4.58 %+4,199.27%
0.11 %-1,115.22%
-0.01 %-66.70%
-0.03 %-191.94%
0.03 %+22.44%
0.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Net Profit Margin of Synektik is 15.00 % in 2025.

Net Profit Margin of Synektik changed from 13.56 % to 15.00 %, representing a 10.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Synektik since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Synektik with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Synektik

All Key Metrics — Synektik